Stratos Wealth Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-5,675
| Closed | -$232K | – | 740 |
|
|
2024
Q3 | $232K | Buy |
5,675
+2
| +0% | +$82 | 0.01% | 674 |
|
|
2024
Q2 | $218K | Buy |
5,673
+83
| +1% | +$3.2K | 0.01% | 645 |
|
|
2024
Q1 | $240K | Sell |
5,590
-1,432
| -20% | -$61.4K | 0.01% | 591 |
|
|
2023
Q4 | $260K | Sell |
7,022
-368
| -5% | -$13.6K | 0.02% | 582 |
|
|
2023
Q3 | $268K | Buy |
+7,390
| New | +$268K | 0.02% | 557 |
|
|
2022
Q3 | – | Sell |
-6,711
| Closed | -$365K | – | 507 |
|
|
2022
Q2 | $365K | Buy |
6,711
+182
| +3% | +$9.9K | 0.03% | 411 |
|
|
2022
Q1 | $356K | Buy |
6,529
+849
| +15% | +$46.3K | 0.03% | 426 |
|
|
2021
Q4 | $313K | Buy |
5,680
+408
| +8% | +$22.5K | 0.02% | 456 |
|
|
2021
Q3 | $252K | Buy |
5,272
+607
| +13% | +$29K | 0.02% | 452 |
|
|
2021
Q2 | $232K | Buy |
4,665
+3
| +0.1% | +$149 | 0.02% | 487 |
|
|
2021
Q1 | $208K | Buy |
+4,662
| New | +$208K | 0.02% | 460 |
|
|
2020
Q3 | – | Sell |
-4,149
| Closed | -$212K | – | 311 |
|
|
2020
Q2 | $212K | Buy |
+4,149
| New | +$212K | 0.07% | 250 |
|